Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of Venom Immunotherapy in Pregnancy: A Multicentre Study.

Allergy·2026
Same author

Depot Extracts for Venom Immunotherapy: A Delphi Consensus on Safety and Efficacy.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Effectiveness and Safety of Dupilumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Associated T2 Comorbidities: One-Year Real Life Round.

Journal of clinical medicine·2026
Same author

Use of lactic acid bacteria to reduce the IgE-reactivity of the arginine kinase allergen from the edible insect Hermetia illucens.

Food research international (Ottawa, Ont.)·2026
Same author

Edible Insects and Allergenic Potential: An Observational Study About In Vitro IgE-Reactivity to Recombinant Pan-Allergens of the Black Soldier Fly (<i>Hermetia illucens</i>) in Patients Sensitized to Crustaceans and Mites.

International journal of molecular sciences·2025
Same author

Gender and Allergy: Mechanisms, Clinical Phenotypes, and Therapeutic Response-A Position Paper from the Società Italiana di Allergologia, Asma ed Immunologia Clinica (SIAAIC).

International journal of molecular sciences·2025

Related Experiment Video

Updated: Mar 27, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.8K

Adherence to Sublingual Immunotherapy.

Cristoforo Incorvaia1, Marina Mauro2, Gualtiero Leo3,4

  • 1Allergy/Pulmonary Rehabilitation, Istituti Clinici di Perfezionamento, via Bignami 1, 20100, Milan, Italy. cristoforo.incorvaia@gmail.com.

Current Allergy and Asthma Reports
|January 14, 2016
PubMed
Summary

Improving adherence to sublingual immunotherapy (SLIT) is crucial for allergy treatment success. Technology-based tools and patient education can help patients complete the recommended 3-year duration for long-lasting benefits.

Keywords:
AdherenceAllergen immunotherapyComplianceEfficacyLong-lasting effectsSublingual immunotherapy

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.2K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

13.0K

Related Experiment Videos

Last Updated: Mar 27, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.8K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.2K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

13.0K

Area of Science:

  • Allergy and Immunology
  • Pharmacology

Background:

  • Adherence is a significant challenge in medical treatments, particularly impacting allergen immunotherapy (AIT).
  • Sublingual immunotherapy (SLIT) adherence is suboptimal, with only 13% of patients completing the recommended 3-year duration, hindering treatment efficacy.

Purpose of the Study:

  • To address the unmet need for improved adherence in sublingual immunotherapy (SLIT).
  • To explore strategies for enhancing patient compliance to achieve the full therapeutic benefits of SLIT.

Main Methods:

  • Review of existing literature on adherence factors in allergen immunotherapy.
  • Evaluation of patient education, monitoring, and technology-based interventions (online platforms, social media, SMS) for improving SLIT adherence.

Main Results:

  • Patient education and accurate monitoring have demonstrated utility in improving adherence.
  • Technology-based tools show promise in enhancing patient compliance with SLIT regimens.

Conclusions:

  • Improved adherence to SLIT is essential for achieving long-lasting allergy modification and clinical benefits.
  • Implementing strategies like patient education and technology integration can help patients complete the 3-year SLIT course, leading to pharmaco-economic advantages.